STAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weaponWorldPing
Image via STAT.

What happened

A Roivant lung disease drug has succeeded in a mid-stage study.

But the drug’s origins are another fascinating aspect to the story.

Key facts

  • Reported by STAT and published Thu, 10 Sep 2026 10:30:00 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

Secret systems used by Israel in mass killings of Gaza civilians revealed in new filmWorldPing
The Guardian

Secret systems used by Israel in mass killings of Gaza civilians revealed in new film

Testimony from Israeli military insiders involved in surveillance and remote killings features in documentary produced by the Guardian Testimony from 24 Israeli military insiders ​on the secret ​systems used in ​the war on Gaza​ has been revealed in…

Brief by WorldPing · Original reporting by The Guardian